Netflix shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 83. Read More...
Investor’s Business Daily
12 Stocks Turned $10,000 To $277,126 In 12 Months
The S&P 500 handed investors a loss of nearly 20% in 2022. But even during such a disappointing year, plenty of moneymaking stocks in the index jumped higher. All told, had you invested $10,000 in January and reinvested your money into the top-performing stock currently in the S&P 500 each month in 2022, including Organon in December, you’d have $277,126 now, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.
